Showing 1131-1140 of 10530 results for "".
The “Aged Microenvironment”: New Understandings of Melanoma Spread and Aggression
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-aged-microenvironment-new-understandings-of-melanoma-spread-and-aggression/20863/New research sheds light on pathways through which melanoma may become more aggressive.Stake a Claim: How to Manage Your Online Directory Listings
https://practicaldermatology.com/topics/practice-management/stake-a-claim-how-to-manage-your-online-directory-listings/20350/A simple guide for making sure your listing is accurate.10 Tips for Managing Hidradenitis Suppurativa
https://practicaldermatology.com/issues/april-2025/10-tips-for-managing-hidradenitis-suppurativa/35602/In an effort to assist the working dermatologist, we have provided the following HS management guide, which supplies actionable insights into optimizing HS management, emphasizing the importance of individualized care, timely interventions, and collaboration with multidisciplinary teams.Warfarin-Induced Nonuremic Calciphylaxis: A Case Study and Overview
https://practicaldermatology.com/youngmd-connect/resident-resource-center/warfarin-induced-nonuremic-calciphylaxis-a-case-study-and-overview/23872/Skin Bugs and Travel Bugs: An Update for Clinicians
https://practicaldermatology.com/topics/general-topics/skin-bugs-and-travel-bugs-an-update-for-clinicians/20601/Skin disease is the third most common medical problem that travelers encounter. Heres' what you need to know about diagnosis and treatment.Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed BRAF-Mutant Stage IV Melanoma
https://practicaldermatology.com/programs/cme/implementing-guideline-concordant-care-for-a-patient-with-newly-diagnosed-braf-mutant-stage-iv-melanoma/36328/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Emerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
https://practicaldermatology.com/programs/cme/emerging-and-practice-changing-data-in-immunotherapy-strategies-for-melanoma/36330/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage IIB/IIC Melanoma
https://practicaldermatology.com/programs/cme/efficacy-and-safety-outcomes-for-adjuvant-immunotherapy-driving-guideline-recommendations-for-stage-iibiic-melanoma/36324/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Clinical Data Prompting Guideline Updates for Subcutaneous ICIs in Melanoma
https://practicaldermatology.com/programs/cme/clinical-data-prompting-guideline-updates-for-subcutaneous-icis-in-melanoma/36329/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage III/IV Melanoma
https://practicaldermatology.com/programs/cme/efficacy-and-safety-outcomes-for-adjuvant-immunotherapy-driving-guideline-recommendations-for-stage-iiiiv-melanoma/36325/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.